Patent details

Basic Information

Publication number:

EP0907365

PCT Application Number:

PCT/SE/97/01998

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP979480654

PCT Publication Number:

WO/98/02445

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL FORMULATION

French Title of Invention:

NOUVELLE FORMULATION

German Title of Invention:

NEUE ARZNEIFORMULIERUNG

SPC Number:

Dates

Filing date:

28/11/1997

Grant date:

07/05/2003

EP Publication Date:

07/05/2003

PCT Publication Date:

11/06/1998

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/04/1999

EP B1 Publication Date:

07/05/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/11/2017

Renunciation date:

Revocation date:

31/10/2007

Annulment date:

Owner

From:

28/11/1997

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

ARONOVA S.A.

From:

22/08/2003

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

SANTESSON Gordon

Address:

Sweden (SE)

2

Name:

NILSSON Hans

Address:

Sweden (SE)

Priority

1

Priority Number:

9604486

Priority Date:

05/12/1996

Priority Country:

Sweden (SE)

2

Priority Number:

846960

Priority Date:

29/04/1997

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/58;

Filing date	Document type	Number of pages